Email this page...
send me a copy of the e-mail
Email Off -->
Navigation Speaker Information
Cynthia Clayton, Alnylam Pharmaceuticals Cynthia Clayton
Alnylam Pharmaceuticals
2012 Annual Conference Committee
Cynthia Clayton
Vice President, Investor Relations & Corporate Communications
Alnylam Pharmaceuticals
Cynthia Clayton joined Alnylam in 2005, where she leads investor and media relations, as well as corporate communications and digital strategies. Prior to joining Alnylam, Ms. Clayton was Director, Investor Relations and Corporate Communications at Synta Pharmaceuticals. In addition, as Senior Manager, Investor and Corporate Communications at Millennium Pharmaceuticals, she worked as part of the team driving the company's strategic communications initiatives, including its first product launch, Velcade. Ms. Clayton began her career in Investor Relations and Corporate Communications at Curis. She earned her B.A. with honors in Communications from the University of Hartford in Connecticut.

 *subject to change


Contact Tammy Dang ( with session inquiries.